Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Allstate Corp (ALL) vs Dolby Laboratories, Inc. (DLB) Price & Performance

Allstate Corp
Dolby Laboratories, Inc.

Price performance

Price movement over the last 24 hours

Key statistics

Allstate Corp vs Dolby Laboratories, Inc. — how do they compare? Allstate Corp trades at $251.71 (market cap $64.77B), while Dolby Laboratories, Inc. trades at $50.11 (market cap $4.71B). The key difference: Allstate Corp is far larger — about 13.8× Dolby Laboratories, Inc.'s market cap, and Dolby Laboratories, Inc. pays the higher dividend (2.83%). Which is the better fit depends on your goals.

ALLDLB
Market Cap
$64.77B$4.71B
Sector
FinancialsIndustrials
52-Week High
$251.61$76.79
52-Week Low
$190.00$49.31
Enterprise Value
$73.56B$4.17B
Dividend Yield
1.72%2.83%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Allstate Corp

Allstate (ALL) trades at $251.61, up 1.19% on the day, with a bullish technical outlook and strong fundamental momentum. The stock shows robust earnings beats in recent quarters, a low P/E of 5.57, and a high ROE of 48.44%. Recent news highlights dividend declarations and anticipation for Q2 2026 earnings, with analysts citing improved underwriting and catastrophe performance as key drivers.

The outlook remains positive given valuation discounts and earnings growth, but risks include hurricane season exposure and competitive pressures. Upside potential is supported by a consensus price target of $251.18, with Wall Street largely holding a buy or neutral stance, though near-term volatility may arise from earnings results due August 6, 2026.

Dolby Laboratories, Inc.

DLB trades at $49.8, down 0.64% on the day, with a bearish technical outlook but strong fundamentals. Recent earnings beats, including Q1 2026 EPS of $1.37 versus $1.31 expected, highlight operational strength. The company maintains high gross margins of 87.44% and positive cash flow, supported by licensing growth and expanding Dolby Atmos adoption.

The stock presents a value opportunity with a P/E of 19.76 below historical averages, and a consensus price target of $87.50 implies significant upside. Risks include cyclical end-market exposure and potential dilution from pipeline developments. Analyst sentiment is moderately bullish, but technical indicators suggest near-term pressure.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Allstate Corp

On the basis of premium sales, Allstate is one of the largest U.S. property and casualty insurers. Personal auto represents the largest percentage of revenue, but the company offers homeowners insurance and other insurance products. Allstate products are sold in North America primarily by about 10,000 agencies.

Read more on ALL

About Dolby Laboratories, Inc.

Dolby Laboratories Inc develops audio and surround sound for cinema, broadcast, home audio systems, in-car entertainment systems, DVD players, games, televisions, and personal computers. The company generates three fourths of its revenue from licensing its technology to consumer electronics manufacturers around the world. The rest of revenue comes from equipment sales to professional producers and audio engineering services.

Read more on DLB